Comparison of Treatment Safety and Patient Survival in Elderly versus Nonelderly Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib Combined with Transarterial Chemoembolization: A Propensity Score Matching Study-Reference-Cited by-同舟云学术

Comparison of Treatment Safety and Patient Survival in Elderly versus Nonelderly Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib Combined with Transarterial Chemoembolization: A Propensity Score Matching Study

Published:2015-02-17 Issue:2 Volume:10 Page:e0117168
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hu Hao,Duan Zhenhua,Long Xiaoran,Hertzanu Yancu,Tong Xiaoqiang,Xu Xiaoquan,Shi Haibin,Liu Sheng,Yang Zhengqiang

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Prospective evaluation of the management of hepatocellular carcinoma in the elderly;V Ozenne;Dig Liver Dis,2011

2. Hepatocellular carcinoma in elderly patients;T Teratani;Cancer,2002

3. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience;F Mirici-Cappa;Gut,2010

4. Geriatric oncology: A clinical approach to the older patient with cancer;L Repetto;Eur J Cancer,2003

5. Antiangiogenic drugs in oncology: A focus on drug safety and the elderly – a mini-review;S Boehm;Gerontology,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumors: Gastrointestinal Cancers;Encyclopedia of Gerontology and Population Aging;2021

2. Tumors: Gastrointestinal Cancers;Encyclopedia of Gerontology and Population Aging;2021

3. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis;BMC Gastroenterology;2018-09-04

4. Tolerance and outcomes of sorafenib in elderly patients treated for advanced hepatocellular carcinoma;Digestive and Liver Disease;2017-09

5. Short outcome comparison of elderly patients versus nonelderly patients treated with transjugular intrahepatic portosystemic stent shunt;Medicine;2017-07